BRCA1-related breast cancer in Austrian breast and ovarian cancer families: specific BRCA1 mutations and pathological characteristics.
about
High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague areaImpact of germline BRCA1 mutations and overexpression of p53 on prognosis and response to treatment following breast carcinoma: 10-year follow up data.Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population.Worse breast cancer prognosis of BRCA1/BRCA2 mutation carriers: what's the evidence? A systematic review with meta-analysis.Pre-test prediction models of BRCA1 or BRCA2 mutation in breast/ovarian families attending familial cancer clinics.Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control.High prevalence of BRCA1 stop mutation c.4183C>T in the Tyrolean population: implications for genetic testingEstimates of the likely prophylactic effect of tamoxifen in women with high risk BRCA1 and BRCA2 mutations.Molecular genetics analysis of hereditary breast and ovarian cancer patients in India.Family history predictors of BRCA1/BRCA2 mutation status among Tunisian breast/ovarian cancer families.Validation of denaturing high performance liquid chromatography as a rapid detection method for the identification of human INK4A gene mutations.A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.Hereditary ovarian cancer in Poland.HER-2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry.Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing.Comprehensive genetic characterization of hereditary breast/ovarian cancer families from Slovakia.Brca1 heterozygous mice have shortened life span and are prone to ovarian tumorigenesis with haploinsufficiency upon ionizing irradiation.Screening breast cancer patients for ATM mutations and polymorphisms by using denaturing high-performance liquid chromatography.Mutations in context: implications of BRCA testing in diverse populations.
P2860
Q24813558-5F153011-B30F-43AF-B6A6-54EE110059E5Q30764147-9127ED39-7BC3-4A0F-9094-04A92DBAB3F8Q33765709-A9A72854-A881-406B-9DDC-5E80268BAC86Q33792732-50EE12BA-FCD9-4E1D-8975-511E4B1EBEBBQ35224593-C13DAB2A-5A1F-4D23-9043-77124C67373BQ35443103-86492767-87A4-4EF6-B5C9-72DF30CAC200Q36117690-62E17577-B4F7-4BCF-91EB-FFCE0535FF66Q36474986-715D7F05-6585-463F-8DE8-FE5BD11432A2Q36643738-84890D76-0F4C-4021-A634-3F8C5748E1A3Q37316299-FDF07114-B4CD-46C2-A967-9C144C9EADAEQ39395789-3F8E6348-AAC6-43B1-A7E7-A583863638C2Q41984636-20457F70-3415-419B-B536-FEC5F5A0D529Q42181679-EF9E6246-1B7D-42E2-85A1-0D109CE5EA47Q43683502-FAEF0318-F7C3-4E63-8BC9-A3260E9936A8Q44202163-7F0D5286-9FB6-43C3-B0FF-206345C507B4Q44215482-9B734901-AE03-4DB9-85C0-1707DF49162CQ44761694-E19AFE8C-68FD-474C-AF73-AD6C6ACFCF24Q45937177-E1FC145F-D581-4C79-9BE5-A5EF4732FCCCQ46597044-B952A470-7CA8-4DA5-8B1D-5CC7B5BF90A4Q47691368-0801C53A-ED5B-44C4-9FCD-B2E674C5939A
P2860
BRCA1-related breast cancer in Austrian breast and ovarian cancer families: specific BRCA1 mutations and pathological characteristics.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
BRCA1-related breast cancer in ...... pathological characteristics.
@en
BRCA1-related breast cancer in ...... pathological characteristics.
@nl
type
label
BRCA1-related breast cancer in ...... pathological characteristics.
@en
BRCA1-related breast cancer in ...... pathological characteristics.
@nl
prefLabel
BRCA1-related breast cancer in ...... pathological characteristics.
@en
BRCA1-related breast cancer in ...... pathological characteristics.
@nl
P2093
P1476
BRCA1-related breast cancer in ...... pathological characteristics.
@en
P2093
A Becherer
B Amirimani
C Zielinski
G Langbauer
P304
P356
10.1002/(SICI)1097-0215(19980729)77:3<354::AID-IJC8>3.0.CO;2-N
P577
1998-07-01T00:00:00Z